Hassan Naqvi

commercialization analyst, Cleveland Clinic Innovations

Hassan Naqvi is part of the Licensing group at Cleveland Clinic Innovations, and is responsible for the evaluation, protection and commercialization of biotechnology innovations across multiple specialties. He manages an extensive portfolio of technologies in the molecular biology space, working closely with the Clinic’s Genomic Medicine Institute and the Pathology and Laboratory Medicine Institute. Mr. Naqvi also oversees license compliance and enforcement issues for CC Innovations. He is an active member of the Association of University Technology Managers, a national professional society of technology licensing professionals. Mr. Naqvi earned his PhD in Cell and Molecular biology from the University of Texas at Austin in 2007, with a focus on Immunology. His post doctoral investigations into the feasibility of utilizing algae lipids as a fuel source led to the formation of OFAT, a Joint Venture between the University of Texas at Austin and Organic Fuels Inc., of Houston, Texas. In addition, he worked with a small chemical company developing novel fluorescent indicators for measuring calcium and sodium levels in living cells.